Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Procysbi (cysteamine bitartrate)
pCPA File Number:
21012
Negotiation Status:
Concluded with an LOI
Indication(s):
Nephropathic cystinosis
Sponsor/Manufacturer:
Horizon Therapeutics Ireland DAC
CADTH Project Number:
SR0526-000
pCPA Engagement Letter Issued:
2018-02-09
Negotiation Process Concluded:
2018-07-20